Long‐term observations of the clinical course after step down of corticosteroid inhalation therapy in adult chronic asthmatics: Correlation with serum levels of eosinophil cationic protein

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Respirology (Carlton South. Print)

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1440-1843.2002.00389.xPMID 12153692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study.

  2001cited by this paper
• Effects Of Theophylline Withdrawal in Well-Controlled Asthmatics Treated with Inhaled Corticosteroid

  2001cited by this paper
• Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild‐to‐moderate asthma: A 4 week randomized multicentre controlled trial

  2001cited by this paper
• Effects of inhaled glucocorticoids on bone density in premenopausal women.

  2001cited by this paper
• Effect of pranlukast on bronchial inflammation in patients with asthma

  2000cited by this paper
• Serum Eosinophil Cationic Protein for Predicting the Prognosis of a Step-Down in Inhaled Corticosteroid Therapy in Adult Chronic Asthmatics

  2000cited by this paper
• Effect of a thromboxane A(2) antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthma.

  2000cited by this paper
• Effect of a Thromboxane A2 Antagonist on Sputum Production and Its Physicochemical Properties in Patients With Mild to Moderate Asthma

  2000cited by this paper
• Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing

  2000cited by this paper
• Repeated antigen inhalations alter chemical mediators that cause asthmatic obstruction in guinea pigs.

  1999cited by this paper
• Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma.

  1999cited by this paper
• Pathology of severe asthma and prognosis

  1999cited by this paper
• Dopamine restores lung ability to clear edema in rats exposed to hyperoxia.

  1999cited by this paper
• Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

  1999cited by this paper
• Treatment of asthma with drugs modifying the leukotriene pathway.

  1999cited by this paper
• Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

  1999cited by this paper
• Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis

  1999cited by this paper
• [Effect of slow-release theophylline on airway inflammation in bronchial asthma].

  1998cited by this paper
• The effect of theophylline on blood and sputum eosinophils and ECP in patients with bronchial asthma.

  1998cited by this paper
• Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.

  1998cited by this paper
• Leukotriene Antagonist Prevents Exacerbation of Asthma During Reduction of High-Dose Inhaled Corticosteroid

  1997cited by this paper
• Pharmacologic Therapy: Managing Asthma Long Term

  1997cited by this paper
• Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.

  1997cited by this paper
• The prolonged survival of human eosinophils with interleukin‐5 and its inhibition by theophylline via apoptosis 1

  1996cited by this paper
• Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.

  1996cited by this paper
• Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.

  1994cited by this paper
• Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma.

  1993cited by this paper
• Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic dermatitis.

  1993cited by this paper
• The role of eosinophils in the pathogenesis of atopic dermatitis ‐ eosinophil granule proteins as markers of disease activity

  1993cited by this paper
• Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

  1992cited by this paper
• Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects.

  1992cited by this paper
• Clinical implications of prostaglandin and thromboxane A2 formation (2).

  1988cited by this paper
• Clinical implications of prostaglandin and thromboxane A2 formation (1).

  1988cited by this paper

• A Review on the Safety and Efficacy of Inhaled Corticosteroids in the Management of Asthma

  2017cites this paper
• Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.

  2017cites this paper
• Efficacy of Seratrodast, a Thromboxane A2 Receptor Inhibitor in a Double Blind Comparative Clinical Trial with Monteluklast

  2016cites this paper
• The risks, benefits, and uncertainties of stepping down asthma medications.

  2014cites this paper
• Beclomethasone versus placebo for chronic asthma

  2005cites this paper
• Issues Associated with Stepwise Management of Bronchial Asthma

  2005cites this paper
• Biomarkers Predicting Response to Corticosteroid Therapy in Asthma

  2005cites this paper
• Inhaled beclomethasone versus placebo for chronic asthma.

  1999cites this paper